WMIF MAIN SITE

2024 Event Site

Past Forum 2024

Summary

The 10th Annual World Medical Innovation Forum brought together leaders in healthcare innovation and investment. Attendees engaged directly with top CEOs, investors, Harvard clinical experts, and policymakers against a backdrop of the latest biotech breakthroughs.

Hosted by Mass General Brigham at the state-of-the-art Encore Boston Harbor, the Forum provided an exclusive environment to connect with key decision-makers.

Sponsored by Bank of America, a global leader in healthcare investment and community engagement.

Speakers

SMid-Cap Biotech Analyst, BofA Global Research

CEO, Tenaya Therapeutics

Director, Crohn’s and Colitis Center, Brigham and Women’s Hospital; – Associate Professor of Medicine, Harvard Medical School

CEO, Capsida Biotherapeutics

Lancer Endowed Chair of Dermatology; – Director, Wellman Center for Photomedicine, Massachusetts General Hospital; – Professor of Dermatology, Harvard Medical School

Director of Academic Research and Education, Mass General Brigham Data Science Office; – Associate Professor, Harvard Medical School

Co-Director, Center for Weight Management and Wellness, Brigham and Women’s Hospital; – Professor of Medicine, Harvard Medical School

Director, Diabetes Clinical Research, Brigham and Women’s Hospital; – Associate Professor, Harvard Medical School

Associate Professor of Medicine, Brigham and Women’s Hospital & Harvard Medical School

Vice President, AstraZeneca Pharmaceuticals

CEO, Mediar Therapeutics

CEO, Moderna

Director, The Mongan Institute, – James J. and Jean H. Mongan Professor of Health Policy and Community Health, Massachusetts General Hospital; – Professor of Medicine, Harvard Medical School

Chief Medical Officer, Bitterroot Bio

Global Healthcare Investment Banking, BofA Securities

Chief Scientific Advisor, Novo Nordisk

CEO & President, Sonoma Biotherapeutics

Professor of Practice of Public Health and Health Policy, Harvard TH Chan School of Public Health; – Research Fellow, Harvard Kennedy School of Government; – Samuel O. Thier Professor of Medicine, Emeritus, Harvard Medical School

President, Brigham and Women’s Hospital and Brigham and Women’s Physicians Organization; – Philip H. Cook Distinguished Professor of Radiology, Harvard Medical School

Chairman & CEO, Pfizer

Washington Healthcare Policy Analyst, BofA Global Research

Enterprise Chief, Radiology, Mass General Brigham; – Juan M. Taveras Professor of Radiology, Harvard Medical School

Chief Integration Officer & Executive Vice President, Mass General Brigham

Corporate Vice President, US Health & Public Sector Industries, Microsoft Corporation

Director of Chemistry, Center for Systems Biology, Massachusetts General Hospital; – Assistant Professor of Medicine, Harvard Medical School

Chairman, President & CEO, Thermo Fisher Scientific

President of Massachusetts, Bank of America

Head of Development, Immuno-Oncology and Cancer Cell Therapy, Astellas Pharma Inc.

Associate Scientist, Massachusetts Eye and Ear; – Associate Professor, Harvard Medical School

Associate Neurologist, Massachusetts General Hospital; – Associate Professor of Neurology, Harvard Medical School

Chair, Department of Neurosurgery, Brigham and Women’s Hospital; – Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School

Associate Director, Center for Brain Tumor Immunology and Immunotherapy, Massachusetts General Hospital; – Assistant Professor of Neurosurgery, Harvard Medical School

Founder, The Chopra Foundation

Chief Innovation Officer, Mass General Brigham

Co-CEO, Amylyx Pharmaceuticals

Chief, Division of Thoracic Surgery, Massachusetts General Hospital; – Hermes C. Grillo Professor of Surgery, Harvard Medical School

Deputy Director, Proactive Health, ARPA-H

Executive Advisor; former CEO & President, Cleveland Clinic

Executive Advisor, Century Therapeutics

Director, MGH Ketamine Clinic and Psychiatrist, Depression Clinical and Research Program, Massachusetts General Hospital; – Associate Professor in Psychiatry, Harvard Medical School

Chief Medical Officer, MassHealth; – Director of Clinical Affairs, UMass Chan Medical School

Biomedical Communications

President, Massachusetts General Hospital and Massachusetts General Physicians Organization (MGPO); – Executive Vice President, Mass General Brigham; – Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

CEO, Skye Bioscience

Surgeon-in-Chief, Mass General Brigham Cancer; – Surgeon-in-Chief, Brigham and Women’s Hospital; – Moseley Professor of Surgery, Harvard Medical School

Acting Chief of Cardiology, Massachusetts General Hospital; – Professor of Medicine, Harvard Medical School

Head of Bank of America Institute

Chair, Department of Psychiatry, Massachusetts General Hospital; – Slater Family Professor of Psychiatry, Harvard Medical School

Chairman & CEO, Genezen

Chairman & CEO, Suffolk

Director of Clinical Research, Mass General Cancer Center; – Professor of Medicine, Harvard Medical School

Physician-in-Chief and Co-Chair, Department of Medicine, Massachusetts General Hospital; – Jackson Professor of Clinical Medicine, Harvard Medical School

CEO, MeiraGTx

Partner, Atlas Venture

Executive Vice President and Vice Dean, Chief of Hospital Operations, NYU Langone Health

Director, Center for Thoracic Cancers Program, Massachusetts General Hospital; – Associate Professor of Medicine, Harvard Medical School

Health Care Facilities and Managed Care Analyst, BofA Global Research

CFO & Treasurer, Mass General Brigham

Chairman & CEO, Xontogeny; – Venture Portfolio Manager, Perceptive Advisors

Specialty Pharma and SMid-Cap Biotech Analyst, BofA Global Research

Director of Bioinformatics, Krantz Center for Cancer Research and Department of Pathology; – Paul C. Zamecnik Chair in Cancer Research, Mass General Cancer Center; – Professor of Pathology, Harvard Medical School

Neurosurgeon; – Director of Image-guided Neurosurgery, Brigham and Women’s Hospital; – Professor of Neurosurgery, Professor of Radiology, Harvard Medical School

Chief of Pediatric Surgery, Massachusetts General Hospital; – Surgeon-in-Chief, Mass General for Children; – Marshall K. Bartlett Professor of Surgery, Harvard Medical School

Director, Memory Division, Massachusetts General Hospital; – Professor of Neurology, Harvard Medical School

Physician; – Former Commissioner, Food and Drug Administration (2017-2019)

Co-Founder & Managing Director, Vida Ventures

Partner, Atlas Venture

Program Manager, ARPA-H

Neurologist, Brigham and Women’s Hospital; – Professor of Neurology, Harvard Medical School

Chief, Metabolism Unit, Massachusetts General Hospital; – Professor of Medicine, Harvard Medical School

Chief, Enterprise Radiation Oncology, Mass General Brigham; – Professor, Harvard Medical School

Director, Mass General Cancer Center; – Kurt J. Isselbacher Professor of Oncology, Harvard Medical School

Director, Gene & Cell Therapy Institute, Mass General Brigham

NRL, McLean; – Assistant Professor Psychiatry, HMS

Associate Professor, Brigham and Women’s Hospital & Harvard Medical School

Secretary of Economic Development, Commonwealth of Massachusetts

Co-Founder & CSO, Mammoth Biosciences

Co-Founder & CEO, Health Assurance Transformation Corp. (HATCo)

Director, Surgical Navigation and Robotics Laboratory, Brigham and Women’s Hospital; – Professor of Radiology, Harvard Medical School

Governor of the Commonwealth of Massachusetts

Chief Business Strategy Officer, Perspective Therapeutics

Director, Center for LAM Research and Clinical Care, Brigham and Women’s Hospital; – Professor of Medicine, Harvard Medical School

Director of Neurotechnology and Neurorecovery, Massachusetts General Hospital; – Senior Lecturer on Neurology, Harvard Medical School

President & CEO, Providence

Director of the Resilience and Prevention Program, Massachusetts General Hospital; – Associate Professor of Psychiatry, Harvard Medical School

EVP, Chief Executive, Providence Clinical Network, Providence

Chief Medical Officer, Eli Lilly and Company

Director of Minimally Invasive Gynecologic Surgery and Infertility, Newton Wellesley Hospital; – Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Founding Director, Neuroregeneration Research Institute, McLean Hospital; – Professor of Neurology and Neuroscience, Harvard Medical School

Head of Global Thematic Investing Research, BofA Global Research

Co-Founder & Chief Operating Officer, Abdera Therapeutics

Krantz Family Center for Cancer Research, Massachusetts General Hospital; – Mass General Cancer Center, Center for Melanoma; – Assistant Professor of Medicine, Harvard Medical School

Executive Director of the Connors Center for Women’s Health and Gender Biology; – Interim Chair, Department of Psychiatry, Brigham and Women’s Hospital; – Paula A. Johnson Professor of Psychiatry in the Field of Women’s Health, Harvard Medical School

Assistant Professor, Brigham and Women’s Hospital & Harvard Medical School

Co-Founder & CEO, Convergent Therapeutics

Chief Medical Officer, MindMed

Director of the Legorreta Center for Clinical Transplantation Tolerance, – A.Benedict Cosimi Chair in Transplant Surgery, Massachusetts General Hospital; – Professor of Surgery, Harvard Medical School

CEO & President, Vertex Pharmaceuticals

Assistant Physician, Mass General Cancer Center; – Assistant Professor, Harvard Medical School

Senior Vice President, Ventures and Business Development & Licensing, Mass General Brigham – Managing Partner, Mass General Brigham Ventures

Co-CEO, Amylyx Pharmaceuticals

President & CEO, Mass General Brigham; – Laurie Carrol Guthart Professor of Medicine, Harvard Medical School

Director of Translational and Clinical Research, Mass General Brigham; – Assistant Professor of Anesthesia, Harvard Medical School

President, The Kraft Group; – Board Chair, Massachusetts General Hospital

Chair, Department of Psychiatry, Yale School of Medicine

CEO, CRISPR Therapeutics

Chief, Division of Infectious Diseases, Brigham and Women’s Hospital; – Harriet Ryan Albee Professor of Medicine, Harvard Medical School

Chief Commercial Officer, Everly Health

Chief Information Officer & SVP, Digital, Mass General Brigham; – Associate Professor of Emergency Medicine, Harvard Medical School

Chief Operating Officer, Best Buy Health

Managing Partner & COO, SV Health Investors

Scientist, Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital; – Professor of Neurology, Harvard Medical School

CEO, ProFound Therapeutics; – CEO-Partner, Flagship Pioneering

Physician-In-Chief and Co-Chair, Department of Medicine, Brigham and Women’s Hospital; – Parker B. Francis Professor of Medicine, Harvard Medical School

Associate Physician, Department of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital; – Associate Professor of Medicine and Biomedical Informatics, Harvard Medical School

Chief Medical & Digital Officer, UC San Diego Health

Enterprise Chief, Pathology, Mass General Brigham; – Benjamin Castleman Professor of Pathology, Harvard Medical School

VP, Ventures & West Coast Head, Eli Lilly

Chief, Division of Rheumatology, Allergy and Immunology; – Director, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital; – Persis, Cyrus and Marlow B. Harrison Professor of Medicine, Harvard Medical School

Health Care Services Analyst, BofA Global Research

Vice Chair for Scientific Innovation, Department of Medicine, Brigham and Women’s Hospital; – Professor of Medicine, Harvard Medical School

Director, MGH Transplant Center; – Paul S. Russell/Warner-Lambert Professor of Surgery, Harvard Medical School

Associate Professor, Brigham and Women’s Hospital & Harvard Medical School

Chief, Nuclear Medicine & Molecular Imaging, Massachusetts General Hospital; – Professor of Radiology, Harvard Medical School

CEO, University of Pennsylvania Health System

Director, Center for Biologics Evaluation and Research, FDA

CEO, Artios Pharma

Director of Cellular Therapy and Paula O’Keeffe Chair in Cancer Research, Krantz Family Center for Cancer Research and Mass General Cancer Center; – Associate Director, Gene and Cell Therapy Institute, Mass General Brigham; – Associate Professor, Harvard Medical School

CEO, Global Corporate Venturing

Chairman & CEO, Mirador Therapeutics

Associate Director, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital; – Professor of Medicine, Harvard Medical School

Chief Medical Information Officer, Mass General Brigham; – Member of the Faculty, Harvard Medical School

Deputy Director, ARPA-H

Chief Information and Digital Officer, Mass General Brigham

Chief Medical Information Officer, Google Cloud

Co-Director, Pediatric Stroke and Cerebrovascular Service, Massachusetts General Hospital; – Associate Professor of Neurology, Harvard Medical School

Entrepreneur in Residence, Mass General Brigham Ventures

Director of Preventive Cardiology, Paul & Phyllis Fireman Endowed Chair in Vascular Medicine, Massachusetts General Hospital; – Associate Professor of Medicine, Harvard Medical School

Managing Director, Novartis Venture Fund

Chair, Department of Obstetrics and Gynecology, Brigham and Women’s Hospital; – Associate Professor, Kate Macy Ladd Professorship, Harvard Medical School

President, Mass General Brigham Healthcare at Home

Senior Vice President, Benefits Executive, Bank of America

CEO, 89bio

Chief Legal Officer and General Counsel, Mass General Brigham

Vice President, Community Health Programs, Mass General Brigham; – Instructor in Medicine, Harvard Medical School

Scientific Director, Center for Transplantation Sciences, Massachusetts General Hospital; – Professor of Surgery, Harvard Medical School

Director, Vaccine and Immunotherapy Center, Massachusetts General Hospital; – Steve and Deborah Gorlin MGH Research Scholar; – Professor of Medicine, Harvard Medical School

Chief Financial Officer, CRISPR Therapeutics

CEO, Regor Therapeutics

CEO & Co-Founder, Fractyl Health

CEO & Founder, Abridge

Chief Genomics Officer, Massachusetts General Hospital; – Professor of Pathology, Harvard Medical School

Chief Scientific Officer, McLean Hospital; – Professor of Psychiatry, Harvard Medical School

Medical Director of Kidney Transplantation, Massachusetts General Hospital; – Harold and Ellen Danser Endowed Chair in Transplantation, Harvard Medical School

President & CEO, Aktis Oncology

Clinician-investigator, Brigham and Women’s Hospital; – Assistant Professor, Harvard Medical School

Health Care Facilities and Managed Care Analyst, BofA Global Research

Director, Scalable Solutions, ARPA-H

Physician-in-Chief, Mass General Brigham Cancer; – Professor of Medicine, Harvard Medical School

Life Science Tools & Diagnostics Analyst, BofA Global Research

Chief Development Officer, Lexeo Therapeutics

Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation

President, Simonovation

President & CEO, Abata Therapeutics

Senior Advisor, Strategic Initiatives Peterson Health Technology Institute

Healthcare Equity Capital Markets, BofA Securities

CEO & Director, Be Biopharma

Assistant Physician, Massachusetts General Hospital; – Assistant Professor, Harvard Medical School

Matthew H. Liang Distinguished Chair in Arthritis and Population Health, Brigham and Women’s Hospital; – Professor of Medicine, Harvard Medical School

Director, Clinical Trials Outcomes Center; – Edward D. Frohlich Distinguished Chair in Cardiovascular Pathophysiology, Brigham and Women’s Hospital; – Professor of Medicine, Harvard Medical School

Chief Investment Officer, Mass General Brigham

Obesity Medicine Physician Scientist, Massachusetts General Hospital; – Associate Professor of Medicine and Pediatrics, Harvard Medical School

Program Manager, ARPA-H

Associate Investigator, Krantz Family Center for Cancer Research; – d’Arbeloff Research Scholar, Massachusetts General Hospital; – Associate Investigator, Krantz Family Center for Cancer Research Harvard Medical School

SMid-Cap Biotech Analyst, BofA Global Research

Executive Director, Mass General Brigham MESH Incubator; – Associate Chair of Innovation & Commercialization, Mass General Brigham Radiology; – Assistant Professor, Harvard Medical School

Chief Medical Officer, Astellas Pharma

Chief Community Health & Health Equity Officer, Mass General Brigham; – Executive Director, Kraft Center for Community Health; – Conrad Taff Endowed Chair and Professor of Pediatrics, Harvard Medical School

Principal Investigator, Wellman Center for Photomedicine, Massachusetts General Hospital; – Remondi Family Endowed MGH Research Institute Chair; – Professor of Pathology, Harvard Medical School

Associate Clinical Director for Innovation, Mass General Cancer Center; – Associate Professor of Medicine, Harvard Medical School

Interventional Radiologist, Massachusetts General Hospital; – Associate Professor, Harvard Medical School

Co-Founder, Chairman & CEO, Frontier Medicines

Associate Commissioner, Women’s Health, U.S. Food and Drug Administration

Investigator, Massachusetts General Hospital; – Assistant Professor, Harvard Medical School

Chief Business Officer, AdvanCell Isotopes

Co-Founder, President & CEO, Seismic Therapeutic

Director, East Coast Ventures, AbbVie

Chief Operating Officer, Mass General Brigham; – Neskey Family Professor of Emergency Medicine, Harvard Medical School

Secretary of Health and Human Services, Commonwealth of Massachusetts

Professor of Pathology, Brigham and Women’s Hospital; – Hansjörg Wyss Professor of Biologically Inspired Engineering, Harvard Medical School

Vice President, Scientific Affairs, Transcend Therapeutics

President & CEO, Takeda

Director, Advanced Research Projects Agency for Health

General Partner, Longwood Fund

Chief, Diabetes Unit, Massachusetts General Hospital; – Associate Professor of Medicine, Harvard Medical School

Chief Medical Officer, Abcuro

Chief Gene Therapy Officer, Kriya Therapeutics

Large/SMid-Cap Biotech and Major Pharma Analyst, BofA Global Research

Head of Research, Gene and Cell Therapy Institute, Mass General Brigham

SMid-Cap Biotech Analyst, BofA Global Research

Principal, RH Capital

Monday, September 23, 2024

Tuesday, September 24, 2024

Wednesday, September 25, 2024

Sponsors